73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Adcetris FDA approval expanded to include later-stage Hodgkin's

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research
Researchers determine epigenetic origin of docetaxel-resistant breast cancer

Researchers determine epigenetic origin of docetaxel-resistant breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), published today in Molecular Cancer Research a study where they identify me

Researchers determine epigenetic origin of docetaxel-resistant breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), published today in Molecular Cancer Research a study where they identify me
Paper filter helps make new cancer drug 1000 times cheaper

Paper filter helps make new cancer drug 1000 times cheaper

by Eindhoven University of TechnologyLech-Gustav Milroy demonstrates the simple separation technique that took the place of the very expensive HPLC. In the background you can see HPLC equipment.

Paper filter helps make new cancer drug 1000 times cheaper

by Eindhoven University of TechnologyLech-Gustav Milroy demonstrates the simple separation technique that took the place of the very expensive HPLC. In the background you can see HPLC equipment.
Researchers 3-D bio-print a model that could lead to improved anticancer drugs and treatments

Researchers 3-D bio-print a model that could lead to improved anticancer drugs and treatments

by University of MinnesotaElectron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer InstituteUniversity of Minnesota researchers have developed a way to study ca

Researchers 3-D bio-print a model that could lead to improved anticancer drugs and treatments

by University of MinnesotaElectron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer InstituteUniversity of Minnesota researchers have developed a way to study ca
A new drug target for triple-negative breast cancer

A new drug target for triple-negative breast cancer

by Louisiana State UniversityCredit: Louisiana State UniversityResearch led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studie

A new drug target for triple-negative breast cancer

by Louisiana State UniversityCredit: Louisiana State UniversityResearch led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studie
Researchers present advance in re-treatment with CAR T therapy

Researchers present advance in re-treatment with CAR T therapy

by Perelman School of Medicine at the University of PennsylvaniaHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Researchers

Researchers present advance in re-treatment with CAR T therapy

by Perelman School of Medicine at the University of PennsylvaniaHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Researchers
When should NHS contact patients over faulty genes?

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre
Growing microtumors in a dish helps rapidly identify genes that drive tumor growth

Growing microtumors in a dish helps rapidly identify genes that drive tumor growth

by Emily Stone,University of Illinois at ChicagoCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113355Researchers have identified a new way to screen genes that cause several d

Growing microtumors in a dish helps rapidly identify genes that drive tumor growth

by Emily Stone,University of Illinois at ChicagoCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113355Researchers have identified a new way to screen genes that cause several d
Two studies describe improved approach to bone marrow transplant

Two studies describe improved approach to bone marrow transplant

by Cincinnati Children's Hospital Medical CenterThese images from scientists at Cincinnati Children's show hematopoietic stem cells (blood stem cells) from donor laboratory mice. The dono

Two studies describe improved approach to bone marrow transplant

by Cincinnati Children's Hospital Medical CenterThese images from scientists at Cincinnati Children's show hematopoietic stem cells (blood stem cells) from donor laboratory mice. The dono
A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and
Researchers identify a new biomarker for personalised treatments against cancer

Researchers identify a new biomarker for personalised treatments against cancer

by Institute for Research in Biomedicine (IRB Barcelona)Different localization of the proteins involved in apoptosis in basal (Ctrl) and upon death receptor induction with TRAIL. Credit: Saška Iv

Researchers identify a new biomarker for personalised treatments against cancer

by Institute for Research in Biomedicine (IRB Barcelona)Different localization of the proteins involved in apoptosis in basal (Ctrl) and upon death receptor induction with TRAIL. Credit: Saška Iv